This review presents a robust strategy to design photosensitizers (PSs) for various species.
Photodynamic therapy (PDT) is a photochemical-based treatment approach that involves the …

Every year novel biologically active compounds are designed as antitumor agents. This
review covers and highlights some of the most important findings described during 2018 …

The success of platinum-based anticancer agents has motivated the exploration of novel
metal-based drugs for several decades, whereas problems such as drug-resistance and …

The clinical success of the platinum-based chemotherapeutic agents has prompted the
investigation of coordination and organometallic complexes of alternative metal centers for …

This review focuses on cytotoxic rhenium compounds in terms of IC 50 values, their mode of
action in biological systems and their status in clinical trials. Biological studies of different …

Ischemia-reperfusion injury (IRI), which describes the cell damage and death that occurs
after blood and oxygen are restored to ischemic or hypoxic tissue, is a significant factor …

Organometallic compounds are increasingly recognized as promising anticancer and
antibiotic drug candidates. Among the transition metal ions investigated for these purposes …

Rhenium (Re) is widely used in the diagnosis and treatment of cancer due to its unique
physical and chemical properties. Re has more valence electrons in its outer shell, allowing …

Despite improvements in the 5-year survival rate to over 80% in cancers, such as Hodgkin
lymphoma and testicular cancer, more aggressive tumors including pancreatic and brain …

The purpose of this review is to give an overview of three important N-bidentate ligands: 1,
10-phenanthroline (phen), 2, 2′-bipyridine (bpy), and ethylenediamine (en). We have not …